Similar articles

• [Immunotherapy for allergic rhinitis induced by Japanese cedar pollens].

  Ohashi Y. Ohashi Y. Arerugi. 2008 May;57(5):519-23. Arerugi. 2008. PMID: 18520172 Review. Japanese. No abstract available.
• Formation of IgE-Allergen-CD23 Complex Changes in Children Treated with Subcutaneous Immunotherapy for Japanese Cedar Pollinosis.

  Asaumi T, Sato S, Yanagida N, Matsuhara H, Kobayashi S, Fukano C, Ohashi-Doi K, Ebisawa M. Asaumi T, et al. Int Arch Allergy Immunol. 2021;182(3):190-194. doi: 10.1159/000510640. Epub 2020 Oct 8. Int Arch Allergy Immunol. 2021. PMID: 33032294
• Long-term immunological effects of Japanese cedar pollen-based subcutaneous immunotherapy.

  Inuo C, Ando H, Tanaka K, Nakajima Y, Tsuge I, Urisu A, Kondo Y. Inuo C, et al. Allergol Int. 2018 Jul;67(3):408-410. doi: 10.1016/j.alit.2017.11.002. Epub 2017 Dec 1. Allergol Int. 2018. PMID: 29198713 No abstract available.
• Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.

  Osada T, Tanaka Y, Yamada A, Sasaki E, Utsugi T. Osada T, et al. Allergol Int. 2018 Oct;67(4):467-474. doi: 10.1016/j.alit.2018.02.004. Epub 2018 Mar 7. Allergol Int. 2018. PMID: 29525489
• Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment.

  Osada T, Okano M. Osada T, et al. Allergol Int. 2021 Jul;70(3):281-290. doi: 10.1016/j.alit.2021.04.002. Epub 2021 May 4. Allergol Int. 2021. PMID: 33962864 Review.